Research programme: malaria vaccine - NIH/Cytos

Drug Profile

Research programme: malaria vaccine - NIH/Cytos

Alternative Names: Malaria VLP vaccine - NIH/Cytos

Latest Information Update: 13 May 2014

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Cytos Biotechnology; National Institutes of Health (USA)
  • Class Parasitic vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Suspended Malaria

Most Recent Events

  • 13 May 2014 Research programme: malaria vaccine - NIH/Cytos is available for licensing as of 05 May 2014. http://www.cytos.com
  • 18 Aug 2011 Suspended for Malaria in USA (unspecified route)
  • 21 Oct 2010 Early research in Malaria in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top